17:54:14 EDT Tue 21 May 2024
Enter Symbol
or Name

Login ID:

Q:TCBP - TC BIOPHARM (HOLDINGS) PLC SPON ADS EACH REP 20 ORD SHS(POST - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TCBP - Q0.11.12·  1.2493  1.109920.40  0.850116:20:12May 1515 min RT 2¢

Recent Trades - Last 10 of 860
Time ETExPriceChangeVolume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-15 08:30U:TCBPNews ReleaseTCBP Announces Launch of Compassionate Use Program for TCB008
2024-05-06 13:01U:TCBPNews ReleaseTC BioPharm Announces Exercise of Warrants for pounds sterling3.1 Million Gross Proceeds
2024-05-06 08:30U:TCBPNews ReleaseTC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
2024-04-04 08:32U:TCBPNews ReleaseTCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
2024-04-02 08:30U:TCBPNews ReleaseTCBP Increasing Treatment Capacity with Expanded Manufacturing Process
2024-03-19 08:30U:TCBPNews ReleaseTCBP Adjourns General Meeting Until a Later Date
2024-03-18 08:30U:TCBPNews ReleaseTCBP Announces Exercise of Series D Warrants For Cash
2024-03-01 08:30U:TCBPNews ReleaseBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"
2024-02-27 17:15U:TCBPNews Release/C O R R E C T I O N -- TC BioPharm/
2024-02-27 08:30U:TCBPNews ReleaseTCBP Announces Shareholder Update Call on March 5th 2024
2024-02-22 09:32U:TCBPNews ReleaseTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial
2024-02-15 08:30U:TCBPNews ReleaseTC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe
2024-02-14 08:30U:TCBPNews ReleaseTCBP Provides Shareholder Update and Highlights Upcoming Milestones
2024-01-29 08:30U:TCBPNews ReleaseTC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'
2024-01-18 08:30U:TCBPNews ReleaseTC BioPharm to Present at the Sequire Investor Summit
2024-01-04 08:30U:TCBPNews ReleaseTC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-01-03 08:30U:TCBPNews ReleaseTC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies
2023-12-22 08:30U:TCBPNews ReleaseTC BioPharm Announces Closing of $3.5 Million Public Offering
2023-12-19 08:00U:TCBPNews ReleaseTC BioPharm Announces Pricing of $3.5 Million Public Offering
2023-12-18 11:15U:TCBPNews ReleaseTC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D